SUBSCRIBE
SUBSCRIBE

Texas

LATEST FROM BIOSPACE
The Growing Presence of Biotech in the World of Social Media
Biotech Bay
The Growing Presence Of Biotech In The World Of Social Media
November 19, 2014
 · 
3 min read
Lone Star Bio
Explosive Compound May Reduce Blood Pressure, Johannes Gutenberg University Study
November 11, 2014
 · 
2 min read
Lone Star Bio
Marijuana’s Long-Term Effects On The Brain, University Of Texas At Dallas Study
November 11, 2014
 · 
3 min read
The 10 Best Cities for Single Biotech Professionals
BioCapital
The 10 Best Cities For Single Biotech Professionals
November 4, 2014
 · 
5 min read
When Will Biosimilars Impact the U.S. Market?
Biotech Bay
When Will Biosimilars Impact The U.S. Market?
October 30, 2014
 · 
4 min read
Off With Their Heads! BioSpace’s Favorite CEOs Who Got The Axe In 2014
Biotech Bay
Off With Their Heads! BioSpace’s Favorite CEOs Who Got The Axe In 2014
October 30, 2014
 · 
6 min read
Lone Star Bio
Mushroom Extract, AHCC, Helpful In Treating HPV, University of Texas Health Science Center Research Shows
October 29, 2014
 · 
2 min read
BioPharm Executive: 5 Reasons To Hate Biotech
Biotech Beach
BioPharm Executive: 5 Reasons To Hate Biotech
October 28, 2014
 · 
6 min read
Lone Star Bio
In Orbit Or On Earth, Implantable Device Will Release Therapeutic Drugs Remotely, Huston Methodist Leading Medicine Study
October 27, 2014
 · 
4 min read
Mylan Inc., Theravance, Inc. Partner Up for $265 Million COPD Pact
Business
Pain Therapeutics Tanks As Pfizer Walks Away From Remoxy® Deal
October 27, 2014
 · 
2 min read
Load More
PRESS RELEASES
Press Releases
Lexicon to Present Preclinical IN VIVO Efficacy Data Demonstrating Ability of New Investigational Compound to Enhance and Maintain Semaglutide-Promoted Weight Loss
November 5, 2024
 · 
5 min read
Press Releases
CNS Pharmaceuticals Announces Virtual Investor KOL Connect Segment
November 5, 2024
 · 
1 min read
Press Releases
bioAffinity Technologies Appoints New Chief Science Officer to Spearhead Product Development
November 4, 2024
 · 
5 min read
Press Releases
Castle Biosciences Reports Third Quarter 2024 Results
November 4, 2024
 · 
20 min read
Press Releases
CNS Pharmaceuticals Granted Exception by Nasdaq to Regain Compliance with Minimum Bid Price Requirement
November 4, 2024
 · 
2 min read
Press Releases
Nexalin Technology Regains Compliance with Nasdaq Continued Listing Requirements
November 4, 2024
 · 
2 min read
Press Releases
Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on November 5th
November 4, 2024
 · 
2 min read
Press Releases
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - November 1, 2024
November 4, 2024
 · 
2 min read
Press Releases
Innovex International, Inc. Schedules Third Quarter 2024 Earnings Release and Conference Call
November 4, 2024
 · 
1 min read
Press Releases
Coya Therapeutics Announces Arun Swaminathan, Ph.D. Assumes New Role as Chief Executive Officer
November 1, 2024
 · 
11 min read
Load More